Status | Study |
Active, not recruiting |
Study Name: Study of Ibrutinib in Patients With Relapsed or Refractory Primary Central Nervous Lymphoma or Intraocular Lymphoma Condition: Primary Central Nervous Lymphoma Intraocular Lymphoma Date: 2015-08-31 Interventions: Drug: Ibrutinib p.o. 560 mg once a day (four 140 mg capsules) for one year (12 cycles of 28 days) |
Withdrawn |
Study Name: Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma Condition: B-cell Adult Acute Lymphoblastic Leukemia Extranodal Marginal Zone B-cell Lymphoma of Mucosa Date: 2014-10-30 Interventions: Biological: rituximab Given IV |
Recruiting |
Study Name: Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas Condition: Adult Grade III Lymphomatoid Granulomatosis B-cell Chronic Lymphocytic Leukemia Date: 2014-08-05 Interventions: Drug: lenalidomide Given PO |
Terminated |
Study Name: CPI-613, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma Condition: B-cell Adult Acute Lymphoblastic Leukemia B-cell Chronic Lymphocytic Leukemia Date: 2014-06-18 Interventions: Drug: 6,8-bis(benzylthio)octanoic acid |
Terminated |
Study Name: Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection Condition: Adult B Acute Lymphoblastic Leukemia Chronic Lymphocytic Leukemia Date: 2014-04-07 Interventions: Drug: Ibrutinib Given PO |
Active, not recruiting |
Study Name: Bortezomib and Filgrastim in Promoting Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma Undergoing Stem Cell Transplant Condition: Adult Grade III Lymphomatoid Granulomatosis B-cell Chronic Lymphocytic Leukemia Date: 2014-01-14 Interventions: Drug: bortezomib Given IV |
Completed |
Study Name: Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant Condition: Adult Grade III Lymphomatoid Granulomatosis Adult Nasal Type Extranodal NK/T-cell Lymphoma Date: 2013-10-08 Interventions: Drug: busulfan Given IV |
Recruiting |
Study Name: Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Myeloid Leukemia With 11q23 (MLL) Date: 2013-04-22 Interventions: Biological: therapeutic allogeneic lymphocytes |
Active, not recruiting |
Study Name: Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma Condition: Adult Grade III Lymphomatoid Granulomatosis Cutaneous B-cell Non-Hodgkin Lymphoma Date: 2013-03-19 Interventions: Biological: autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T |
Recruiting |
Study Name: Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas Condition: Adult Grade III Lymphomatoid Granulomatosis Adult Nasal Type Extranodal NK/T-cell Lymphoma Date: 2013-02-27 Interventions: Drug: brentuximab vedotin Give |